Clinical Trial Evaluating Methotrexate or Leflunomide + Targeted Therapy Versus Methotrexate or Leflunomide + Sulfasalazine + Hydroxychloroquine in Patients With Rheumatoid Arthritis and Insufficient Response to Methotrexate or Leflunomide

Abroad (travel likely)RecruitingPHASE4

Conditions

Rheumatoid Arthritis · Insufficient Response to Methotrexate or Leflunomide

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Hôpitaux Universitaires de Strasbourg, Strasbourg, France
Contact: Study coordinator (Jacques-Eric Gottenberg) · jacques-eric.gottenberg@chru-strasbourg.fr · 3 88 12 81 89
Contact: Principal Investigator (Jacques-Eric Gottenberg)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of Resveratrol in Patients With Rheumatoid Arthritis.

Rheumatic Arthritis · Rheumatoid Arthritis (RA) Prevention · Inflamation

Abroad (travel likely)Recruiting

Cairo, Egypt

Effect of MTX Discontinuation on Shingrix Response in RA

Rheumatoid Arthritis

Abroad (travel likely)Recruiting

Seoul, South Korea

Post-marketing Re-evaluation of WangBi Granules for Rheumatoid Arthritis

Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE4

Beijing, China

RA-PRO PRAGMATIC TRIAL

Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE3

Auburn, United States · Birmingham, United States